# Baidu Capital

> Baidu Capital is a VC fund in Beijing backing Health Care and Manufacturing. See 22 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 22
- Last investment: Mar 2025
- Lead investor: 59%
- Fund size: $3B
- Last fund: Oct 2016
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/bv-baidu-venture/
- Website: https://www.baidu-venture.com

Baidu Capital is a VC fund in Beijing focused on Health Care and Manufacturing. Baidu Capital is the venture arm of Baidu invests in mid-to-late projects in the pan-net field.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 18% |
| Manufacturing | 4 | 18% |
| Artificial Intelligence | 4 | 18% |
| Medical | 3 | 14% |
| Robotics | 3 | 14% |

40 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 8 | 36% |
| Seed | 4 | 18% |
| Series C | 4 | 18% |
| Series B | 2 | 9% |
| Series D | 2 | 9% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 18 | 82% |
| United States | 1 | 5% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Vita Dynamics | Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently. | $13.8M | Seed | Mar 21, 2025 |  |
| Breath Medical | Breath Medical is a medical device developer in the field of otolaryngology. It independently develops and promotes consumables and equipment, providing a total solution for ENT surgery. Its two core products are “low temperature plasma RF surgery system” and “fully degraded”. Sinus drug stent". |  | Series C | Nov 07, 2023 |  |
| Main Function Intelligence | Main Function Intelligence is a provider of unmanned mining transportation systems that focus on intelligent mining and wire-controlled wide-body vehicles. |  | Series A | Oct 09, 2023 |  |
| Zhongke Jiahe | Zhongke Jiahe develops compilation technology and aspires to build a universal, low-cost, high-performance fundamental software tool chain. |  | Seed | Aug 15, 2023 |  |
| Agibot | Agibot develops humanoid robots designed to perform various real-world tasks using artificial intelligence. The company focuses on creating robots that can engage in fine-grained manipulation and collaborate with other robots in diverse scenarios. AgiBot's products aim to enhance the efficiency of operations across multiple industries byintegrating advanced robotic capabilities. The company continuously explores new applications for its technology, contributing to the evolution of robotics in everyday environments. Through its innovative approach, AgiBot addresses the growing demand for automation and intelligent systems in the workforce. |  | Seed | May 31, 2023 |  |
| Agibot | Agibot develops humanoid robots designed to perform various real-world tasks using artificial intelligence. The company focuses on creating robots that can engage in fine-grained manipulation and collaborate with other robots in diverse scenarios. AgiBot's products aim to enhance the efficiency of operations across multiple industries byintegrating advanced robotic capabilities. The company continuously explores new applications for its technology, contributing to the evolution of robotics in everyday environments. Through its innovative approach, AgiBot addresses the growing demand for automation and intelligent systems in the workforce. |  | Series A | May 31, 2023 |  |
| Agibot | Zhiyuan Robotics mainly integrates AI and robots deeply, develops and produces general-purpose humanoid robots and embodied intelligence, and other products. |  | Series A | May 31, 2023 |  |
| Enze Kangtai | Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic products and exosome research. |  | Series A | Mar 03, 2023 |  |
| Jinghe Optoelectronics | Jinghe Optoelectronics provides integrated solutions for digital automotive lighting software and hardware systems. |  | Series A | Dec 17, 2021 |  |
| Weimai | Weimai is a developer of a health application platform intended to provide medical and health services. The company's health application platform offers an Internet-based appointment, distribution, maternal and child disease management, grading diagnosis and treatment as well as remote diagnosis, and medical records management, providing userswith a family doctor application in every home. | $100M | Series C | Dec 15, 2020 |  |

10 of 22 investments shown.

## Co-investors
- [Tencent](https://shizune.co/investors/profile/tencent) — VC Fund, 3 deals together
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 2 deals together
- [Vision Plus Capital](https://shizune.co/investors/profile/vision-plus) — VC Fund, 2 deals together
- [3E Bioventures](https://shizune.co/investors/profile/3e-bioventures) — VC Fund, 1 deal together
- [All-Stars Investment](https://shizune.co/investors/profile/all-stars-investment) — VC Fund, 1 deal together
- [Ameba Capital](https://shizune.co/investors/profile/ameba-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Baidu Capital invest in?

Baidu Capital invests primarily in Health Care, Manufacturing and Artificial Intelligence startups, most often at Series A and Seed stage. Most of the 22 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Baidu Capital last invest?

The most recent investment recorded for Baidu Capital closed in Mar 2025. Shizune tracks 22 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co